We have demonstrated that LDL apheresis via dextran sulfate absorption removes plasma PF4 and reduces the amount of PF4 on the surface of circulating PLTs. Reduced surface PF4 may decrease antibody formation and/or recognition by HITT antibodies.
These data provide a potential explanation for the near lack of HITT in hypercholesterolemic patients undergoing LDL apheresis.
They also suggest the possibility that LDL apheresis using dextran sulfate adsorption may have therapeutic value in the treatment of HITT.
2011-05-06
Eng.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Transfusion. 2011 May;51(5):1022-9
© Galenicom 1999-2013